Irma Febo
San Juan, PRNPI 1285661769
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Viiv Healthcare Company at 50.6% of the total.
Across 8 payments — averaging $51.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$209
- Gilead$131
- Bavarian Nordic A/s$49
- Johnson & Johnson$25
Across 124 payments — averaging $4462.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$202K
- Modernatx, Inc.$162K
- Janssen Research & Development, LLC$109K
- Sanofi US Services Inc.$37K
- Sanofi Pasteur Inc.$25K
- GSK$16K
- plus $1K from 1 others
What the payments were for
- Food & beverage$413100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 3 | $209 |
| Gilead | 3 | $131 |
| Bavarian Nordic A/s | 1 | $49 |
| Johnson & Johnson | 1 | $25 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.